Carmona-Sánchez R

Language: Spanish
References: 21
Page: 294-297
PDF size: 38.31 Kb.

Text Extraction

No abstract

REFERENCES

1. El-Serag HB, Talley NJ. Systematic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharnacol Ther 2004; 19: 643-54.

2. El-Serag HB, Talley NJ. Systematic review: Health-related quality of live in functional dyspepsia. Aliment Pharmacol Ther 2003; 18: 387-93.

3. Feinle-Bisset C, Vozzo OR, Horowitz M, Talley NJ. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-81.

4. Gotthard R, Bodemar G, Brodin U, Jonsson KA. Treatment with cimetidine, antiacids or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7-18.

5. Nyren O, Adami HO, Bates S, et al. Abscence of therapeutic benefit from antiacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339-43.

6. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. The Cochrane database of systematic reviews 2006 Issue 3. Disponible en: www.cochrane.org/reviews/en/ab001960.html

7. Moayyedi P, Soo S, Deeks J, et al. Systematic review: antiacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003; 17: 1215-27.

8. Redstone HA, Barrowman R, Veldhuyzen Van Zanten SJ. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001; 15: 1291-9.

9. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ: The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127: 1329-37.

10. Meineche-Schmidt V. Classification of dyspepsia and response to treatment with proton pump inhibitors. Aliment Pharmacol Ther 2004; 20: 1171-9.

11. Veldhuyzen van Zaten SJO, Jones MJ, Virlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001; 96: 689-96.

12. Abraham NS, Moayyedi P, Daniels B, Veldhuyzen van Zanten SJ. Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther 2004; 19: 631-41.

13. Tack J, Vos R, Bisschops G, Tougas G, Janssens J, Phillips T. Effect of tegaserod, a 5-HT4 receptor antagonist, on sensory and motor function of the proximal stomach in functional dyspepsia. Gastroenterology 2005; 128 (Suppl. 2): A-94 (abstract).

14. Mearin F, Rodrigo L, Pérez-Mota A, et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: arandomized, double-masked trial. Clin Gastroenterol Hepatol 2004; 2: 301-8.

15. Hallerback BI, Bommelaer G, Bredberg E, et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther 2002; 16: 959-67.

16. Hiyama T, Yoshihara M, Matsuo K, et al. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J Gastroenterol Hepatol 2007; 22: 304-10.

17. Choi NK, Hahn S, Park BJ. Increase in mortality rate following coprescription of cisapride and contraindicated drugs. Ann Pharmacother 2007; 41: 667-73.

18. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug insight: from disturbed motility to disordered movement-review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 138-48.

19. FDA Public Health Advisory. Tegaserod maleate (marketed as Zelnorm). March 30, 2007. Available at: http://www.fda.gob/cder/drug/advisory/tegaserod.html.

20. Moayyedi P, Soo S, Deeks J, Delaney B, et al. Eradication of Helicobacter Pylori for non-ulcer dyspepsia. The Cochrane database of systematic reviews 2006. Disponible en: www.cochrane.org/reviews/en/ab002096.html.

21. Hojo M, Miwa H, Yokoyama T, et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: Systematic review. J Gastroenterol 2005; 40: 1036-42.